Company Filing History:
Years Active: 2020
Title: Ana Bejanariu: Innovator in Hepatitis B Research
Introduction
Ana Bejanariu is a prominent inventor based in Boulogne-Billancourt, France. She has made significant contributions to the field of medical research, particularly in the development of innovative solutions for hepatitis B virus (HBV) treatment. Her work focuses on the use of lentiviral vectors to enhance immune responses against HBV antigens.
Latest Patents
Ana Bejanariu holds a patent for "Lentiviral vectors for expression of hepatitis B virus (HBV) antigens." This invention relates to nucleic acids, including lentiviral vectors and lentiviral vector particles, that encode various HBV antigens. These include the envelop surface of genotypes A and/or C, polymerase, HBX protein, and consensus core antigens. The invention also encompasses methods for producing these vectors and their medicinal applications, particularly in inducing immune responses in humans against HBV antigens. She has 1 patent to her name.
Career Highlights
Ana Bejanariu is currently associated with Theravectys, a company dedicated to advancing therapeutic solutions for viral infections. Her role at Theravectys allows her to leverage her expertise in the development of innovative medical technologies.
Collaborations
Ana collaborates with notable colleagues, including Mohamad Fakruddin Jamiluddin and Emeline Sarry. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in medical innovation.
Conclusion
Ana Bejanariu is a key figure in the field of hepatitis B research, with her innovative work on lentiviral vectors paving the way for new therapeutic approaches. Her contributions are vital in the ongoing fight against viral infections, showcasing the importance of innovation in medicine.